"Pulmonary Surfactants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.
| Descriptor ID |
D011663
|
| MeSH Number(s) |
D27.505.954.796.600
|
| Concept/Terms |
Pulmonary Surfactants- Pulmonary Surfactants
- Surfactants, Pulmonary
- Pulmonary Surfactant
- Surfactant, Pulmonary
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Surfactants".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Surfactants".
This graph shows the total number of publications written about "Pulmonary Surfactants" by people in this website by year, and whether "Pulmonary Surfactants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 0 | 5 |
| 1997 | 4 | 0 | 4 |
| 1998 | 4 | 1 | 5 |
| 1999 | 3 | 2 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2018 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Surfactants" by people in Profiles.
-
Khanuja K, Jayakumaran J, Al-Kouatly HB, McLaren RA. Antenatal steroids and neonatal outcomes in late preterm births with pregestational diabetes. Int J Gynaecol Obstet. 2024 Aug; 166(2):767-774.
-
Slovinsky WS, Romero F, Sales D, Shaghaghi H, Summer R. The involvement of GM-CSF deficiencies in parallel pathways of pulmonary alveolar proteinosis and the alcoholic lung. Alcohol. 2019 11; 80:73-79.
-
Fessler MB, Summer RS. Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease. Am J Respir Cell Mol Biol. 2016 05; 54(5):624-35.
-
Sherman TI, Moya F, Simmons PD, Kurtz D, Shaffer TH. Parental preferences regarding administration of an animal-derived versus a synthetic medication to newborn infants. J Neonatal Perinatal Med. 2016; 9(1):7-14.
-
Spitler G, Spitz H, Glasser S, Hoffman MK, Bowen J. In vitro dissolution of uranium-contaminated soil in simulated lung fluid containing a pulmonary surfactant. Health Phys. 2015 Mar; 108(3):336-43.
-
Bhatia R, Penfil S. Calfactant: is there a potential role in acute lung injury? Pediatr Crit Care Med. 2014 May; 15(4):385.
-
Wolfson MR, Wu J, Hubert TL, Gregory TJ, Mazela J, Shaffer TH. Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS. Pediatr Res. 2012 Oct; 72(4):375-83.
-
Shaffer TH, Alapati D, Greenspan JS, Wolfson MR. Neonatal non-invasive respiratory support: physiological implications. Pediatr Pulmonol. 2012 Sep; 47(9):837-47.
-
Shaffer TH, Wolfson MR. Translational research: matching experimental models with therapeutic interventions. Pediatr Crit Care Med. 2012 May; 13(3):369-70.
-
Bhatia R, Shaffer TH, Hossain J, Fisher AO, Horner LM, Rodriguez ME, Penfil S, Theroux MC. Surfactant administration prior to one lung ventilation: physiological and inflammatory correlates in a piglet model. Pediatr Pulmonol. 2011 Nov; 46(11):1069-78.